Evidence map›Paper›PMID 22965830›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2013

No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression.

Richard Musil, Peter Zill, Florian Seemüller, Brigitta Bondy, Michael Obermeier, Ilja Spellmann, Wolfram Bender, Mazda Adli, Isabella Heuser, Joachim Zeiler and 7 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The Impact ofInternational journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. The glutamate system as a therapeutic target and impact of genes on suicidality.European archives of psychiatry and clinical neuroscience · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

Richard MusilDepartment of Psychiatry and Psychotherapy, Psychiatric Clinic, Ludwig-Maximilians-University Munich, Nussbaumstrasse 7, 80336, Munich, Germany. richard.musil@med.uni-muenchen.de
Peter Zill
Florian Seemüller
Brigitta Bondy
Michael Obermeier
Ilja Spellmann
Wolfram Bender
Mazda Adli
Isabella Heuser
Joachim Zeiler
Wolfgang Gaebel
Wolfgang Maier
Marcella Rietschel
Dan Rujescu
Rebecca Schennach
Hans-Jürgen Möller
Michael Riedel
Ludwig-Maximilians-Universität München · DECharité - Universitätsmedizin Berlin · DEAuguste-Viktoria-Klinik · DECentral Institute of Mental Health · DEHeinrich Heine University Düsseldorf · DEIsar-Amper-Klinikum München-Ost · DEKrankenhaus vom Roten Kreuz · DEUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of the brain-derived neurotrophic factor (BDNF) in the pathophysiology of major depressive disorder (MDD) remains to be elucidated. Recent post hoc analyses indicated a potential association of three polymorphisms in the BDNF gene with worse treatment outcome in patients with the subtype of melancholic depression. We aimed at replicating these findings in a German naturalistic multicenter follow-up. Three polymorphisms in the BDNF gene (rs7103411, rs6265 (Val66Met) and rs7124442) were genotyped in 324 patients with MDD and 470 healthy controls. We applied univariate tests and logistic regression models stratifying for depression subtype and gender. The three polymorphisms were not associated with MDD as diagnosis. Further, no associations were found in univariate tests. With logistic regression, we only found a tendency towards an association of the rs6265 (Val66Met) polymorphism with overall response to treatment (response rates: GG (val/val) < GA (val/met) < AA (met/met); p = 0.0129) and some gender differences for the rs6265 (Val66Met) and rs7103411 polymorphisms. Treatment outcome stratified for subtypes of depression did not differ significantly between the investigated polymorphisms or using haplotype analyses. However, results showed a tendency towards significance. At this stage, we cannot support an influence of these three polymorphisms. Further studies in larger patient samples to increase sample sizes of subgroups are warranted.

Indexed as

PharmacogeneticsAdultAntidepressive AgentsBrain-Derived Neurotrophic FactorFemaleFollow-Up StudiesGenetic Association StudiesGenotypeHumansMajor Depressive DisorderMaleMiddle AgedPolymorphism, Single NucleotideStatistics, NonparametricAntidepressive AgentsBrain-Derived Neurotrophic Factor

Identifiers

PMID22965830
OpenAlexW1996371590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.